Mirna Therapeutics, Inc. and Horizon Discovery Ltd. Publication Elucidates Novel miR-34 Tumor Suppressor Pathway, Underscores miR-34 as Important Anticancer Approach
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
AUSTIN, Texas & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Mirna Therapeutics, Inc. and Horizon Discovery Ltd. announced today the publication of new data providing further confirmation that microRNA-34 (miR-34), and the tumor suppressor pathways it controls, is an important potential target for a wide variety of cancers. The data are published in Molecular Therapy, the official journal of the American Society of Gene and Cell Therapy, and reveals a novel mechanism through which miR-34 exerts its tumor suppressor function in cancers.
Help employers find you! Check out all the jobs and post your resume.
AUSTIN, Texas & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Mirna Therapeutics, Inc. and Horizon Discovery Ltd. announced today the publication of new data providing further confirmation that microRNA-34 (miR-34), and the tumor suppressor pathways it controls, is an important potential target for a wide variety of cancers. The data are published in Molecular Therapy, the official journal of the American Society of Gene and Cell Therapy, and reveals a novel mechanism through which miR-34 exerts its tumor suppressor function in cancers.
Help employers find you! Check out all the jobs and post your resume.